Evaluation of molecular imaging of DNA synthesis for diagnosis, theraputic value and recurrent diagnosis of head and neck tumor
Not Applicable
Recruiting
- Conditions
- Head and neck carcinoma
- Registration Number
- JPRN-UMIN000006466
- Lead Sponsor
- Juntendo university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Pregnancy or lactating womem, or women with suspected pregnancy. 2.Patient with severe underlying disease having risk of liver dysfunction, renal dysfunction and any metabolic damage. 3.Just after surgery and/or trauma. 4.Poor controled diabetics. 5.Anaphylaxis of thiotymidine or tymidine. 6.Those who are determined as not appropriate for the study by physician in chief.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method As a surrogate marker of pretreatment and theraputic evaluation, 4DST-PET could be superior than FDG-PET.
- Secondary Outcome Measures
Name Time Method